Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Quince Therapeutics, Inc. | 18,724 | reported | 02 Jan 2026 | tx 6+184,006 |
| BioXcel Therapeutics, Inc. | 17,000 | reported | 09 Jan 2026 | tx 6+97,167 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Quince Therapeutics, Inc. | 18,724 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 30,282 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 26 Jun 2023 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 54,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 01 Mar 2021 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 4,167 | 0.00 USD | deriv |